Join
Live feed
·
PRReleasevia Quantisnow
Axovant Gene Therapies Ltd. logo

Axovant Gene Therapies Receives Rare Pediatric Disease Designation for AXO-AAV-GM1 for GM1 Gangliosidosis

ByQuantisnow·Wall Street's wire, on your screen.
AXGT· Axovant Gene Therapies Ltd.
Health Care
Full content unavailable. See the original source below.
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AXGT (Axovant Gene Therapies Ltd.) and more on Quantisnow.